Global Dog Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Dog Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dog Vaccines include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dog Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Dog Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Dog Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dog Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Dog Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dog Vaccines sales, projected growth trends, production technology, application and end-user industry.
Dog Vaccines Segment by Company
Zoetis (Pfizer)
Merck Animal Health
Eli Lilly
Bayer Healthcare
Virbac
Vetoquinol S.A
Merial (Sanofi)
Heska Co.
Ceva
Boehringer Ingelheim
Dog Vaccines Segment by Type
Recombinant Vaccines
Subunit Vaccines
Inactivated Vaccines
Toxoid Vaccines
Attenuated Live Vaccines
Conjugate Vaccines
DNA Vaccines
Dog Vaccines Segment by Application
Below 6 Months
Above Months
Dog Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dog Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Dog Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dog Vaccines include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dog Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Dog Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Dog Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dog Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Dog Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dog Vaccines sales, projected growth trends, production technology, application and end-user industry.
Dog Vaccines Segment by Company
Zoetis (Pfizer)
Merck Animal Health
Eli Lilly
Bayer Healthcare
Virbac
Vetoquinol S.A
Merial (Sanofi)
Heska Co.
Ceva
Boehringer Ingelheim
Dog Vaccines Segment by Type
Recombinant Vaccines
Subunit Vaccines
Inactivated Vaccines
Toxoid Vaccines
Attenuated Live Vaccines
Conjugate Vaccines
DNA Vaccines
Dog Vaccines Segment by Application
Below 6 Months
Above Months
Dog Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dog Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
193 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Dog Vaccines Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Dog Vaccines Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Dog Vaccines Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Dog Vaccines Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Dog Vaccines Market Dynamics
- 2.1 Dog Vaccines Industry Trends
- 2.2 Dog Vaccines Industry Drivers
- 2.3 Dog Vaccines Industry Opportunities and Challenges
- 2.4 Dog Vaccines Industry Restraints
- 3 Dog Vaccines Market by Manufacturers
- 3.1 Global Dog Vaccines Revenue by Manufacturers (2020-2025)
- 3.2 Global Dog Vaccines Sales by Manufacturers (2020-2025)
- 3.3 Global Dog Vaccines Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Dog Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Dog Vaccines Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Dog Vaccines Manufacturers, Product Type & Application
- 3.7 Global Dog Vaccines Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dog Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dog Vaccines Players Market Share by Revenue in 2024
- 3.8.3 2024 Dog Vaccines Tier 1, Tier 2, and Tier 3
- 4 Dog Vaccines Market by Type
- 4.1 Dog Vaccines Type Introduction
- 4.1.1 Recombinant Vaccines
- 4.1.2 Subunit Vaccines
- 4.1.3 Inactivated Vaccines
- 4.1.4 Toxoid Vaccines
- 4.1.5 Attenuated Live Vaccines
- 4.1.6 Conjugate Vaccines
- 4.1.7 DNA Vaccines
- 4.2 Global Dog Vaccines Sales by Type
- 4.2.1 Global Dog Vaccines Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Dog Vaccines Sales by Type (2020-2031)
- 4.2.3 Global Dog Vaccines Sales Market Share by Type (2020-2031)
- 4.3 Global Dog Vaccines Revenue by Type
- 4.3.1 Global Dog Vaccines Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Dog Vaccines Revenue by Type (2020-2031)
- 4.3.3 Global Dog Vaccines Revenue Market Share by Type (2020-2031)
- 5 Dog Vaccines Market by Application
- 5.1 Dog Vaccines Application Introduction
- 5.1.1 Below 6 Months
- 5.1.2 Above Months
- 5.2 Global Dog Vaccines Sales by Application
- 5.2.1 Global Dog Vaccines Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Dog Vaccines Sales by Application (2020-2031)
- 5.2.3 Global Dog Vaccines Sales Market Share by Application (2020-2031)
- 5.3 Global Dog Vaccines Revenue by Application
- 5.3.1 Global Dog Vaccines Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Dog Vaccines Revenue by Application (2020-2031)
- 5.3.3 Global Dog Vaccines Revenue Market Share by Application (2020-2031)
- 6 Global Dog Vaccines Sales by Region
- 6.1 Global Dog Vaccines Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Dog Vaccines Sales by Region (2020-2031)
- 6.2.1 Global Dog Vaccines Sales by Region (2020-2025)
- 6.2.2 Global Dog Vaccines Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Dog Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Dog Vaccines Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Dog Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Dog Vaccines Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Dog Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Dog Vaccines Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Dog Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Dog Vaccines Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Dog Vaccines Revenue by Region
- 7.1 Global Dog Vaccines Revenue by Region
- 7.1.1 Global Dog Vaccines Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Dog Vaccines Revenue by Region (2020-2025)
- 7.1.3 Global Dog Vaccines Revenue by Region (2026-2031)
- 7.1.4 Global Dog Vaccines Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Dog Vaccines Revenue (2020-2031)
- 7.2.2 North America Dog Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Dog Vaccines Revenue (2020-2031)
- 7.3.2 Europe Dog Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Dog Vaccines Revenue (2020-2031)
- 7.4.2 Asia-Pacific Dog Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Dog Vaccines Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Dog Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Zoetis (Pfizer)
- 8.1.1 Zoetis (Pfizer) Comapny Information
- 8.1.2 Zoetis (Pfizer) Business Overview
- 8.1.3 Zoetis (Pfizer) Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Zoetis (Pfizer) Dog Vaccines Product Portfolio
- 8.1.5 Zoetis (Pfizer) Recent Developments
- 8.2 Merck Animal Health
- 8.2.1 Merck Animal Health Comapny Information
- 8.2.2 Merck Animal Health Business Overview
- 8.2.3 Merck Animal Health Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Merck Animal Health Dog Vaccines Product Portfolio
- 8.2.5 Merck Animal Health Recent Developments
- 8.3 Eli Lilly
- 8.3.1 Eli Lilly Comapny Information
- 8.3.2 Eli Lilly Business Overview
- 8.3.3 Eli Lilly Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Eli Lilly Dog Vaccines Product Portfolio
- 8.3.5 Eli Lilly Recent Developments
- 8.4 Bayer Healthcare
- 8.4.1 Bayer Healthcare Comapny Information
- 8.4.2 Bayer Healthcare Business Overview
- 8.4.3 Bayer Healthcare Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Bayer Healthcare Dog Vaccines Product Portfolio
- 8.4.5 Bayer Healthcare Recent Developments
- 8.5 Virbac
- 8.5.1 Virbac Comapny Information
- 8.5.2 Virbac Business Overview
- 8.5.3 Virbac Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 Virbac Dog Vaccines Product Portfolio
- 8.5.5 Virbac Recent Developments
- 8.6 Vetoquinol S.A
- 8.6.1 Vetoquinol S.A Comapny Information
- 8.6.2 Vetoquinol S.A Business Overview
- 8.6.3 Vetoquinol S.A Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Vetoquinol S.A Dog Vaccines Product Portfolio
- 8.6.5 Vetoquinol S.A Recent Developments
- 8.7 Merial (Sanofi)
- 8.7.1 Merial (Sanofi) Comapny Information
- 8.7.2 Merial (Sanofi) Business Overview
- 8.7.3 Merial (Sanofi) Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Merial (Sanofi) Dog Vaccines Product Portfolio
- 8.7.5 Merial (Sanofi) Recent Developments
- 8.8 Heska Co.
- 8.8.1 Heska Co. Comapny Information
- 8.8.2 Heska Co. Business Overview
- 8.8.3 Heska Co. Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 Heska Co. Dog Vaccines Product Portfolio
- 8.8.5 Heska Co. Recent Developments
- 8.9 Ceva
- 8.9.1 Ceva Comapny Information
- 8.9.2 Ceva Business Overview
- 8.9.3 Ceva Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Ceva Dog Vaccines Product Portfolio
- 8.9.5 Ceva Recent Developments
- 8.10 Boehringer Ingelheim
- 8.10.1 Boehringer Ingelheim Comapny Information
- 8.10.2 Boehringer Ingelheim Business Overview
- 8.10.3 Boehringer Ingelheim Dog Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.10.4 Boehringer Ingelheim Dog Vaccines Product Portfolio
- 8.10.5 Boehringer Ingelheim Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Dog Vaccines Value Chain Analysis
- 9.1.1 Dog Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dog Vaccines Production Mode & Process
- 9.2 Dog Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dog Vaccines Distributors
- 9.2.3 Dog Vaccines Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

